Quoin Pharmaceuticals Appoints New CEO and Directors
Ticker: QNRX · Form: 8-K · Filed: Jul 8, 2025 · CIK: 1671502
| Field | Detail |
|---|---|
| Company | Quoin Pharmaceuticals, Ltd. (QNRX) |
| Form Type | 8-K |
| Filed Date | Jul 8, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, board-of-directors, ceo-appointment
TL;DR
Quoin Pharma has a new CEO, Eyal Lifschitz, and two new directors, effective July 3rd.
AI Summary
On July 3, 2025, Quoin Pharmaceuticals, Ltd. announced changes in its board of directors and executive officers. The company elected two new directors, Dr. Yossi Gross and Mr. Eyal Lifschitz, and appointed Mr. Eyal Lifschitz as Chief Executive Officer. These changes are effective immediately.
Why It Matters
The appointment of a new CEO and directors often signals a strategic shift or a new direction for the company, which could impact its future performance and stock value.
Risk Assessment
Risk Level: medium — Changes in key leadership positions like CEO and board members can introduce uncertainty and potential shifts in strategy, impacting the company's stability and future prospects.
Key Players & Entities
- Quoin Pharmaceuticals, Ltd. (company) — Filing company
- July 3, 2025 (date) — Effective date of changes
- Dr. Yossi Gross (person) — Newly elected director
- Mr. Eyal Lifschitz (person) — Newly elected director and appointed CEO
- Cellect Biotechnology Ltd. (company) — Former company name
- Cellect Biomed Ltd. (company) — Former company name
FAQ
Who are the newly elected directors at Quoin Pharmaceuticals?
Dr. Yossi Gross and Mr. Eyal Lifschitz were elected as new directors.
Who has been appointed as the new Chief Executive Officer?
Mr. Eyal Lifschitz has been appointed as the new Chief Executive Officer.
When were these changes effective?
The changes were effective as of July 3, 2025.
What was Quoin Pharmaceuticals' former name?
Quoin Pharmaceuticals was formerly known as Cellect Biotechnology Ltd. and Cellect Biomed Ltd.
What is the principal executive office address for Quoin Pharmaceuticals?
The principal executive offices are located at 42127 Pleasant Forest Court, Ashburn, VA 20148-7349.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 8, 2025 by Dr. Yossi Gross regarding Quoin Pharmaceuticals, Ltd. (QNRX).